Concise Review: Perspectives and Clinical Implications of Bone Marrow and Circulating Stem Cell Defects in Diabetes

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Stem Cells

• Publication date

  2017-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/stem.2445PMID 27401837
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell‐based therapies for cardiac repair: a meeting report on scientific observations and European regulatory viewpoints

  2016cited by this paper
• Distinct bone marrow blood vessels differentially regulate hematopoiesis

  2016cited by this paper
• NETosis Delays Diabetic Wound Healing in Mice and Humans

  2016cited by this paper
• Polychromatic Flow Cytometry

  2016cited by this paper
• Role of Acid Sphingomyelinase in Shifting the Balance Between Proinflammatory and Reparative Bone Marrow Cells in Diabetic Retinopathy

  2016cited by this paper
• Plerixafor improves the endothelial health balance. The effect of diabetes analysed by polychromatic flow cytometry.

  2016cited by this paper
• Diabetic hepatosclerosis: another diabetes microvascular complication?

  2016cited by this paper
• Sitagliptin plus granulocyte colony-stimulating factor in patients suffering from acute myocardial infarction: A double-blind, randomized placebo-controlled trial of efficacy and safety (SITAGRAMI trial).

  2016cited by this paper
• Levels of Circulating Progenitor Cells, Cardiovascular Outcomes and Death: A Meta-Analysis of Prospective Observational Studies.

  2016cited by this paper
• Adult Bone Marrow Cell Therapy for Ischemic Heart Disease Evidence and Insights From Randomized Controlled Trials

  2015cited by this paper
• A look at the bone marrow predicts the global outcome.

  2015cited by this paper
• Circulating CD34+ Progenitor Cells and Risk of Mortality in a Population With Coronary Artery Disease

  2015cited by this paper
• Bone Marrow Macrophages Contribute to Diabetic Stem Cell Mobilopathy by Producing Oncostatin M

  2015cited by this paper
• Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials.

  2015cited by this paper
• Meta-analysis of cell therapy trials for patients with heart failure.

  2015cited by this paper
• Direct effects of DPP-4 inhibition on the vasculature. Reconciling basic evidence with lack of clinical evidence.

  2015cited by this paper
• Efficacy of CD34+ Stem Cell Therapy in Nonischemic Dilated Cardiomyopathy Is Absent in Patients With Diabetes but Preserved in Patients With Insulin Resistance

  2015cited by this paper
• Plasticity of hematopoietic stem cells.

  2015cited by this paper
• Immune Intervention for Type 1 Diabetes, 2013–2014

  2015cited by this paper
• Transplanted Bone Marrow-Derived Cells Contribute to Human Adipogenesis.

  2015cited by this paper
• Circulating IGF-I and IGFBP3 Levels Control Human Colonic Stem Cell Function and Are Disrupted in Diabetic Enteropathy.

  2015cited by this paper
• Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor

  2015cited by this paper
• Type 2 diabetes mellitus

  2015cited by this paper
• Circulating Progenitor Cell Count Predicts Microvascular Outcomes in Type 2 Diabetic Patients.

  2015cited by this paper
• Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.

  2015cited by this paper
• Bone marrow-derived TNF-α causes diabetic neuropathy in mice

  2015cited by this paper
• Sensory neuropathy hampers nociception-mediated bone marrow stem cell release in mice and patients with diabetes

  2015cited by this paper
• The Role of Bone Marrow Cells in the Phenotypic Changes Associated with Diabetic Nephropathy

  2015cited by this paper
• The dipeptidyl peptidase-4 inhibitor Saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients

  2014cited by this paper
• Ex Vivo Molecular Rejuvenation Improves the Therapeutic Activity of Senescent Human Cardiac Stem Cells in a Mouse Model of Myocardial Infarction

  2014cited by this paper
• Concise Review: Diabetes, the Bone Marrow Niche, and Impaired Vascular Regeneration

  2014cited by this paper
• Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in New-Onset Type 1 Diabetes: A Multicenter Analysis

  2014cited by this paper
• Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity.

  2014cited by this paper
• Pathophysiological role of enhanced bone marrow adipogenesis in diabetic complications

  2014cited by this paper
• Bone marrow failure and the telomeropathies.

  2014cited by this paper
• Processing of CXCL 12 impedes the recruitment of endothelial progenitor cells in diabetic wound healing

  2014cited by this paper
• Diabetes Causes Bone Marrow Autonomic Neuropathy and Impairs Stem Cell Mobilization via Dysregulated p66Shc and Sirt1

  2014cited by this paper
• Characterization of Circulating and Endothelial Progenitor Cells in Patients With Extreme-Duration Type 1 Diabetes

  2014cited by this paper
• Short-term inhibition of DPP-4 enhances endothelial regeneration after acute arterial injury via enhanced recruitment of circulating progenitor cells.

  2014cited by this paper
• MicroRNA miR-27b Rescues Bone Marrow–Derived Angiogenic Cell Function and Accelerates Wound Healing in Type 2 Diabetes Mellitus

  2014cited by this paper
• Processing of CXCL12 impedes the recruitment of endothelial progenitor cells in diabetic wound healing

  2014cited by this paper
• Proliferative Retinopathy in Type 1 Diabetes Is Associated With Cerebral Microbleeds, Which Is Part of Generalized Microangiopathy

  2014cited by this paper
• Diabetes Gets on the Nerves of the Bone Marrow Niche

  2014cited by this paper
• An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy

  2013cited by this paper
• Endothelial progenitor cell: a blood cell by many other names may serve similar functions

  2013cited by this paper
• Quality-Control Culture System Restores Diabetic Endothelial Progenitor Cell Vasculogenesis and Accelerates Wound Closure

  2013cited by this paper
• Diabetic Retinopathy, Its Progression, and Incident Cardiovascular Events in the ACCORD Trial

  2013cited by this paper
• Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model

  2013cited by this paper
• Impaired Endothelial Progenitor Cell Mobilization and Dysfunctional Bone Marrow Stroma in Diabetes Mellitus

  2013cited by this paper
• Mechanisms of diabetic complications.

  2013cited by this paper
• Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.

  2013cited by this paper
• Autologous Bone Marrow–Derived Cell Therapy in Patients With Critical Limb Ischemia: A Meta-Analysis of Randomized Controlled Clinical Trials

  2013cited by this paper
• Rhythmic modulation of the hematopoietic niche through neutrophil clearance.

  2013cited by this paper
• A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications

  2013cited by this paper
• Dipeptidyl peptidase-4 inhibition and vascular repair by mobilization of endogenous stem cells in diabetes and beyond.

  2013cited by this paper
• Diabetes impairs mobilization of stem cells for the treatment of cardiovascular disease: a meta-regression analysis.

  2013cited by this paper
• Diabetes Causes Bone Marrow Endothelial Barrier Dysfunction by Activation of the RhoA–Rho-Associated Kinase Signaling Pathway

  2013cited by this paper
• Diabetes Impairs Stem Cell and Proangiogenic Cell Mobilization in Humans

  2013cited by this paper
• Arteriolar niches maintain haematopoietic stem cell quiescence

  2013cited by this paper
• Adrenergic nerves govern circadian leukocyte recruitment to tissues.

  2012cited by this paper
• Fusion of bone marrow‐derived cells with renal tubules contributes to renal dysfunction in diabetic nephropathy

  2012cited by this paper
• Worse Clinical Outcomes in Acute Myocardial Infarction Patients with Type 2 Diabetes Mellitus: Relevance to Impaired Endothelial Progenitor Cells Mobilization

  2012cited by this paper
• Flow Cytometric Identification and Functional Characterization of Immature and Mature Circulating Endothelial Cells

  2012cited by this paper
• It Is All in the Blood: The Multifaceted Contribution of Circulating Progenitor Cells in Diabetic Complications

  2012cited by this paper
• Global Remodeling of the Vascular Stem Cell Niche in Bone Marrow of Diabetic Patients: Implication of the microRNA-155/FOXO3a Signaling Pathway

  2012cited by this paper
• Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use

  2012cited by this paper
• Endothelial progenitor cells in diabetes mellitus

  2012cited by this paper
• Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy

  2012cited by this paper
• Phenotypic and functional characterization of endothelial colony forming cells derived from human umbilical cord blood.

  2012cited by this paper
• Pro-angiogenic cell-based therapy for the treatment of ischemic cardiovascular diseases.

  2012cited by this paper
• Targeting the CXCR4–CXCL12 Axis Mobilizes Autologous Hematopoietic Stem Cells and Prolongs Islet Allograft Survival via Programmed Death Ligand 1

  2011cited by this paper
• A low frequency of pancreatic islet insulin-expressing cells derived from cord blood stem cell allografts in humans

  2011cited by this paper
• Diabetes mellitus, fasting glucose, and risk of cause-specific death.

  2011cited by this paper
• CXCR4 Antagonist AMD3100 Accelerates Impaired Wound Healing in Diabetic Mice

  2011cited by this paper
• Stromal cell-derived factor-1 (SDF-1)/chemokine (C-X-C motif) receptor 4 (CXCR4) axis activation induces intra-islet glucagon-like peptide-1 (GLP-1) production and enhances beta cell survival

  2011cited by this paper
• Does microvascular disease predict macrovascular events in type 2 diabetes?

  2011cited by this paper
• Immunological applications of stem cells in type 1 diabetes.

  2011cited by this paper
• Is bone marrow another target of diabetic complications?

  2011cited by this paper
• Autologous Umbilical Cord Blood Transfusion in Young Children With Type 1 Diabetes Fails to Preserve C-Peptide

  2011cited by this paper
• Endothelial and cardiac progenitors: boosting, conditioning and (re)programming for cardiovascular repair.

  2011cited by this paper
• Diabetes: impaired damage control

  2011cited by this paper
• Diabetic stem-cell "mobilopathy".

  2011cited by this paper
• Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice

  2011cited by this paper
• Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death

  2011cited by this paper
• Diabetes Impairs Hematopoietic Stem Cell Mobilization by Altering Niche Function

  2011cited by this paper
• The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes

  2010cited by this paper
• Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice

  2010cited by this paper
• Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature.

  2010cited by this paper
• Potential manipulation of endothelial progenitor cells in diabetes and its complications

  2010cited by this paper
• The Mobilization and Effect of Endogenous Bone Marrow Progenitor Cells in Diabetic Wound Healing

  2010cited by this paper
• Decreased Circulating Progenitor Cell Number and Failed Mechanisms of Stromal Cell-Derived Factor-1α Mediated Bone Marrow Mobilization Impair Diabetic Tissue Repair

  2010cited by this paper
• Time Course and Mechanisms of Circulating Progenitor Cell Reduction in the Natural History of Type 2 Diabetes

  2010cited by this paper
• Circulating Endothelial Progenitor Cells Do Not Contribute to Plaque Endothelium in Murine Atherosclerosis

  2010cited by this paper
• Diabetes Mellitus Induces Bone Marrow Microangiopathy

  2010cited by this paper
• Differentiation of Bone Marrow-Derived Endothelial Progenitor Cells Is Shifted into a Proinflammatory Phenotype by Hyperglycemia

  2009cited by this paper
• Long-Term Prognosis of Diabetic Patients With Critical Limb Ischemia

  2009cited by this paper
• Human CD133+ Progenitor Cells Promote the Healing of Diabetic Ischemic Ulcers by Paracrine Stimulation of Angiogenesis and Activation of Wnt Signaling

  2009cited by this paper
• Poor functional recovery after transplantation of diabetic bone marrow stem cells in ischemic myocardium.

  2009cited by this paper
• Autologous Umbilical Cord Blood Transfusion in Very Young Children With Type 1 Diabetes

  2009cited by this paper
• Bone marrow adipocytes as negative regulators of the hematopoietic microenvironment

  2009cited by this paper

• Periostin ameliorates impaired osteogenic differentiation of bone marrow mesenchymal stem cells from T2DM rats via modulating autophagy and cellular senescence.

  2026cites this paper
• Oncostatin M is dispensable for the regulation of hematopoietic stem/progenitor cell traffic by neutrophils

  2025cites this paper
• Antioxidants improve the viability of diabetic bone marrow MSCs without rescuing their pro-regenerative secretome function.

  2025cites this paper
• Advancements in utilizing CD34+ stem cells for repairing diabetic vascular damage.

  2025cites this paper
• Effect of type 2 diabetes mellitus microenvironment on osteogenic capacity of bone marrow mesenchymal stem cells.

  2025cites this paper
• Will diabetes mellitus induce aplastic anemia by immune factors?: A two-sample and mediation Mendelian randomization study

  2025cites this paper
• Lysyl oxidase-dependent bone marrow stiffening promotes neutrophil activation in diabetes

  2025cites this paper
• Adenosine Monophosphate-Activated Protein Kinase Activation and Mammalian Target of Rapamycin Complex 1 Inhibition: A Mechanistic Rationale for Anti-Aging Therapy in Type 2 Diabetes

  2025cites this paper
• Fine Tuning Mesenchymal Stromal Cells – Code For Mitigating Kidney Diseases

  2024cites this paper
• Transcriptomic Profile of Lin-Sca1+c-kit (LSK) cells in db/db mice with long-standing diabetes

  2024cites this paper
• SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect. State of the Art

  2024cites this paper
• Transcriptomic Profile of Lin−Sca1+c-kit (LSK) cells in db/db mice with long-standing diabetes

  2024cites this paper
• Photobiomodulation inhibits retinal degeneration in diabetic mice through modulation of stem cell mobilization and gene expression.

  2024cites this paper
• Restoration of blood vessel regeneration in the era of combination SGLT2i and GLP-1RA therapy for diabetes and obesity.

  2023cites this paper
• Recent progress in bone-repair strategies in diabetic conditions

  2023cites this paper
• Unveiling the Genetic Footprint: Exploring Somatic Mutations in Peripheral Arterial Disease Progression

  2023cites this paper
• Neuronal-Hematopoietic Cell Fusion in Diabetic Neuropathy.

  2023cites this paper
• Hematopoietic stem cells and metabolic deterioration in Alström syndrome, a rare genetic model of the metabolic syndrome.

  2023cites this paper
• Photobiomodulation Therapy to Autologous Bone Marrow in Humans Significantly Increases the Concentration of Circulating Stem Cells and Macrophages: A Pilot Study

  2022cites this paper
• Astaxanthin Protects against Hyperglycemia-Induced Oxidative and Inflammatory Damage to Bone Marrow and to Bone Marrow-Retained Stem Cells and Restores Normal Hematopoiesis in Streptozotocin-Induced Diabetic Mice

  2022cites this paper
• Three-dimensional printed dosage forms based on disease-focussed perspectives.

  2022cites this paper
• Stem Cells in Regenerative Medicine

  2022cites this paper
• Neuritin Promotes Bone Marrow-Derived Mesenchymal Stem Cell Migration to Treat Diabetic Peripheral Neuropathy

  2022cites this paper
• Peptidoglycan-Mediated Bone Marrow Autonomic Neuropathy Impairs Hematopoietic Stem/Progenitor Cells via a NOD1-Dependent Pathway in db/db Mice

  2022cites this paper
• Glycaemic Control Achieves Sustained Increases of Circulating Endothelial Progenitor Cells in Patients Hospitalized for Decompensated Diabetes: An Observational Study

  2022cites this paper
• Hematological abnormalities among adults with type 1 diabetes mellitus at the University of Gondar Comprehensive Specialized Hospital

  2022cites this paper
• Endothelial Progenitor Cells in Coronary Artery Disease: From Bench to Bedside

  2022cites this paper
• Assessment of the Relationship Between CD34 Antigen and Vitamin D Level and Insulin Resistance in Patients With Type 2 Diabetes.

  2022cites this paper
• Transforming growth factor-β1/Thrombospondin-1/CD47 axis mediates dysfunction in CD34+ cells derived from diabetic older adults.

  2022cites this paper
• Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19.

  2022cites this paper
• Hematopoietic Stem Cells in Type 1 Diabetes

  2021cites this paper
• Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trial

  2021cites this paper
• Can intermittent fasting help in stem-cell rejuvenation?

  2021cites this paper
• The Effect of Diabetes Mellitus on IGF Axis and Stem Cell Mediated Regeneration of the Periodontium

  2021cites this paper
• (Accepted/In press). Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy. Current diabetes reports.

  2021cites this paper
• Personalized Cell Therapy for Patients with Peripheral Arterial Diseases in the Context of Genetic Alterations: Artificial Intelligence-Based Responder and Non-Responder Prediction

  2021cites this paper
• The Fate Status of Stem Cells in Diabetes and its Role in the Occurrence of Diabetic Complications

  2021cites this paper
• Oral glucose feeding enhances adherence of quiescent lymphocytes to fibronectin via non-canonical insulin signalling

  2021cites this paper
• Inhibition of SGLT2 Rescues Bone Marrow Cell Traffic for Vascular Repair: Role of Glucose Control and Ketogenesis

  2021cites this paper
• Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy

  2021cites this paper
• Impairment of type H vessels by NOX2-mediated endothelial oxidative stress: critical mechanisms and therapeutic targets for bone fragility in streptozotocin-induced type 1 diabetic mice

  2021cites this paper
• The Bluegreen Algae (AFA) Consumption over 48 h Increases the Total Number of Peripheral CD34+ Cells in Healthy Patients: Effect of Short-Term and Long-Term Nutritional Supplementation (Curcumin/AFA) on CD34+ Levels (Blood)

  2020cites this paper
• DMSO_A_233538 161..174

  2020cites this paper
• Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence

  2020cites this paper
• Metabolic Coordination of Pericyte Phenotypes: Therapeutic Implications

  2020cites this paper
• Diabetes mellitus impairs circulating proangiogenic granulocytes

  2020cites this paper
• SGLT-2 Inhibitors and Circulating Progenitor Cells in Diabetes.

  2020cites this paper
• Bone Marrow at Initial Diagnosis: Clinical Associations and Approach to Diagnosis

  2020cites this paper
• Monodispersed β‐Glycerophosphate‐Decorated Bioactive Glass Nanoparticles Reinforce Osteogenic Differentiation of Adipose Stem Cells and Bone Regeneration In Vivo

  2020cites this paper
• Pharmacologic PPAR-γ Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine Diabetes

  2020cites this paper
• Effects of glucose variability on hematopoietic stem/progenitor cells in patients with type 1 diabetes

  2020cites this paper
• Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double‐blind, placebo‐controlled trial

  2020cites this paper
• When Good Guys Turn Bad: Bone Marrow’s and Hematopoietic Stem Cells’ Role in the Pathobiology of Diabetic Complications

  2020cites this paper
• The impact of ageing on lipid-mediated regulation of adult stem cell behavior and tissue homeostasis.

  2020cites this paper
• Activation of Bone Marrow Adaptive Immunity in Type 2 Diabetes: Rescue by Co-stimulation Modulator Abatacept

  2020cites this paper
• SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control

  2020cites this paper
• Menstruation: science and society

  2020cites this paper
• Evaluation of the In Vitro Damage Caused by Lipid Factors on Stem Cells from a Female Rat Model of Type 2 Diabetes/Obesity and Stress Urinary Incontinence

  2020cites this paper
• Diabetes pharmacotherapy and circulating stem/progenitor cells. State of the art and evidence gaps.

  2020cites this paper
• Decreased 18F-Fluorodeoxyglucose Uptake in Lumbar Vertebrae of Stroke Patients

  2020cites this paper
• Peripheral Levels of EPCs, T Cells, and Macrophages’ as Possible Predictive Biomarkers of Acute Myocardial Infarction

  2020cites this paper
• Antioxidants

  2020cites this paper
• Melatonin preconditioning is an effective strategy for mesenchymal stem cell‐based therapy for kidney disease

  2019cites this paper
• Dipeptidyl dipeptidase-4 inhibitor recovered ischemia through an increase in vasculogenic endothelial progenitor cells and regeneration-associated cells in diet-induced obese mice

  2019cites this paper
• Circulating stem cells and cardiovascular outcomes: from basic science to the clinic.

  2019cites this paper
• A Systematic Review of Human Trials Using Stem Cell Therapy for Erectile Dysfunction.

  2019cites this paper
• Identification of Human Postnatal Progenitor Cells with Multifaceted Regenerative Functions

  2019cites this paper
• Stem Cells from a Female Rat Model of Type 2 Diabetes/Obesity and Stress Urinary Incontinence Are Damaged by In Vitro Exposure to its Dyslipidemic Serum, Predicting Inadequate Repair Capacity In Vivo

  2019cites this paper
• Recent advances in ultrasound-triggered therapy

  2019cites this paper
• MCP-1 Feedback Loop Between Adipocytes and Mesenchymal Stromal Cells Causes Fat Accumulation and Contributes to Hematopoietic Stem Cell Rarefaction in the Bone Marrow of Patients With Diabetes. Diabetes , 67 (7), 1380-1394.

  2019cites this paper
• Angiogenic abnormalities in diabetes mellitus: mechanistic and clinical aspects.

  2019cites this paper
• Vascular Regenerative Cell Exhaustion in Diabetes: Translational Opportunities to Mitigate Cardiometabolic Risk.

  2019cites this paper
• Characterization and Differentiation of Circulating Blood Mesenchymal Stem Cells and the Role of Phosphatidylinositol 3-Kinase in Modulating the Adhesion

  2019cites this paper
• Cytokine‐induced hematopoietic stem and progenitor cell mobilization: unraveling interactions between stem cells and their niche

  2019cites this paper
• Bone marrow pericyte dysfunction in individuals with type 2 diabetes

  2019cites this paper
• The Shifting Nature of Endothelial Progenitor Cells in Aortic Stenosis.

  2019cites this paper
• Effects of Hypoglycemia on Circulating Stem and Progenitor Cells in Diabetic Patients

  2018cites this paper
• Dipeptidyl dipeptidase-4 inhibitor, MK-0626, promotes bone marrow-derived endothelial progenitor cell bioactivities for vascular regeneration in diet-induced obese mice

  2018cites this paper
• Dyslipidemia Is a Major Factor in Stem Cell Damage Induced by Uncontrolled Long-Term Type 2 Diabetes and Obesity in the Rat, as Suggested by the Effects on Stem Cell Culture.

  2018cites this paper
• Neuropathy and inflammation in diabetic bone marrow

  2018cites this paper
• Effects of SGLT2 Inhibitors on Circulating Stem and Progenitor Cells in Patients With Type 2 Diabetes

  2018cites this paper
• Inhibition of Retinoic Acid Production Expands a Megakaryocyte-Enriched Subpopulation with Islet Regenerative Function

  2018cites this paper
• ADSC-conditioned media elicit an ex vivo anti-inflammatory macrophage response.

  2018cites this paper
• Pharmacologic targeting of the diabetic stem cell mobilopathy

  2018cites this paper
• Mesenchymal stem cells pretreated with melatonin ameliorate kidney functions in a rat model of diabetic nephropathy.

  2018cites this paper
• Bone, inflammation and the bone marrow niche in chronic kidney disease: what do we know?

  2018cites this paper
• MCP-1 Feedback Loop Between Adipocytes and Mesenchymal Stromal Cells Causes Fat Accumulation and Contributes to Hematopoietic Stem Cell Rarefaction in the Bone Marrow of Patients With Diabetes

  2018cites this paper
• Identification of megakaryocytes as a target of advanced glycation end products in diabetic complications in bone marrow

  2018cites this paper
• Circulating Pro-Vascular Progenitor Cell Depletion During Type 2 Diabetes

  2018cites this paper
• Autologous Cell Therapy for Peripheral Arterial Disease: Systematic Review and Meta-Analysis of Randomized, Nonrandomized, and Noncontrolled Studies.

  2017cites this paper
• Intrinsic Mesenchymal Stem Cell Dysfunction in Diabetes Mellitus: Implications for Autologous Cell Therapy

  2017cites this paper
• Diabetes mellitus as a poor mobilizer condition.

  2017cites this paper
• Angiotensin-(1-7): A Target for Stem Cell Mobilopathy and Vascular Repair in Diabetes

  2017cites this paper
• THE EFFECT OF VITAMIN D AND CALCIUM SUPPLEMENT ON HBA 1 C AND BLOOD PRESSURE IN PATIENTS WITH TYPE 2 DIABETES : A QUASI-EXPERIMENTAL STUDY

  2017cites this paper
• Immunotherapy for type 1 diabetes

  2017cites this paper
• Reduced circulating stem cells associate with excess fasting and post-load NEFA exposure in healthy adults with normal glucose tolerance.

  2017cites this paper
• CD34+ cell count predicts long lasting life in the oldest old.

  2017cites this paper
• Thrombospondin-1-Derived Peptide RFYVVMWK Improves the Adhesive Phenotype of CD34+ Cells from Atherosclerotic Patients with Type 2 Diabetes

  2017cites this paper
• Reversal of Bone Marrow Mobilopathy and Enhanced Vascular Repair by Angiotensin-(1-7) in Diabetes

  2016influential citation